Patents, Public Health, and International Law: The Eli Lilly NAFTA Chapter 11 Case

Patents, Public Health, and International Law: The Eli Lilly NAFTA Chapter 11 Case

0 Anmeldelser
0
Episode
782 of 2233
Længde
1T 25M
Sprog
Engelsk
Format
Kategori
Fakta

In recent years, controversy has arisen over perceived conflicts between intellectual property protection and public health, and also over the role of international investment rules that allow corporations to sue governments before international tribunals. A new case combines both issues. Pharmaceutical company Eli Lilly has filed a claim before a NAFTA tribunal, alleging that Canadian court decisions in response to challenges from the Canadian generic drug industry have unfairly invalidated some of the company's Canadian patents. Eli Lilly has asked for CDN$500 million as compensation for the damages it has suffered. This forum assembles experts with different perspectives on the case to sort through the various intellectual property, public health, and international law issues involved: Is the "promise utility" doctrine relied on by the Canadian courts credible? Is public health undermined or helped by this shift, which will favor the generic drug industry? Is it appropriate for international tribunals to play a role here? Please join us for a spirited discussion. Hosted on Acast. See acast.com/privacy for more information.


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036
Cover for Patents, Public Health, and International Law: The Eli Lilly NAFTA Chapter 11 Case

Other podcasts you might like ...